RSV vaccines market Overview
Respiratory syncytial virus infections are recognized among the prevalent respiratory diseases, accounting for approximately 33 million new cases in children aged under five years, annually. Currently, several traditional techniques are available for treating these infections, although none of them have been competent enough to reduce the healthcare burden of RSV diseases. In order to address...
0 Comments 0 Shares 316 Views